Clinical Trial Update: Bendamustine and Mitoxantrone in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia [Phase 2]

View source ↗

Summary

A phase 2 clinical trial evaluating the combination of bendamustine and mitoxantrone in patients with relapsed or refractory chronic lymphocytic leukemia has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Novantrone (mitoxantrone)
• Treanda (Bendamustine)

Snippet

Sponsor: German CLL Study Group | Conditions: Chronic Lymphocytic Leukemia | Phase 2 | Status: COMPLETED